Alexandra D. Carides

4.5k total citations · 1 hit paper
36 papers, 3.5k citations indexed

About

Alexandra D. Carides is a scholar working on Surgery, Physiology and Pharmacology. According to data from OpenAlex, Alexandra D. Carides has authored 36 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 12 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Alexandra D. Carides's work include Nausea and vomiting management (23 papers), Anesthesia and Pain Management (22 papers) and Pathogenesis and Treatment of Hiccups (7 papers). Alexandra D. Carides is often cited by papers focused on Nausea and vomiting management (23 papers), Anesthesia and Pain Management (22 papers) and Pathogenesis and Treatment of Hiccups (7 papers). Alexandra D. Carides collaborates with scholars based in United States, Canada and Netherlands. Alexandra D. Carides's co-authors include Judith K. Evans, Kevin Horgan, Paul J. Hesketh, Steven M. Grunberg, David Warr, Richard J. Gralla, Fausto Roila, Arlene Taylor, James C. Street and Sant P. Chawla and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Alexandra D. Carides

35 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

2003 593 citations Paul J. Hesketh, Steven M. Grunberg et al. profile →

Peers

Countries citing papers authored by Alexandra D. Carides

Since Specialization

Citations

This map shows the geographic impact of Alexandra D. Carides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra D. Carides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra D. Carides more than expected).

Fields of papers citing papers by Alexandra D. Carides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra D. Carides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra D. Carides. The network helps show where Alexandra D. Carides may publish in the future.

Co-authorship network of co-authors of Alexandra D. Carides

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra D. Carides. A scholar is included among the top collaborators of Alexandra D. Carides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra D. Carides. Alexandra D. Carides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count 2014 ·Journal of NeuroVirology ·(unknown), Ahmet Y. Ozdemir, Alexandra D. Carides, (unknown), William Yen, (unknown), Ronald J. Ellis, Dianne Langford	5
2	Analysis of Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting with Moderately and Highly Emetogenic Chemotherapy 2013 ·Future Oncology ·Alex Molassiotis, Allison Martin Nguyen, Cynthia N. Rittenberg, (unknown), Alexandra D. Carides	2
3	Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC) 2010 ·Supportive Care in Cancer ·Paul J. Hesketh, David Warr, James C. Street, Alexandra D. Carides	10
4	Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy 2010 ·Supportive Care in Cancer ·David Warr, James C. Street, Alexandra D. Carides	91
5	PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- and High-grade (Gleason Score 6 and 7) Cancer 2009 ·Urology ·Steven A. Kaplan, Claus G. Roehrborn, Alan G. Meehan, (unknown), Alexandra D. Carides, Bruce Binkowitz, Norman Heyden, E. Darracott Vaughan	37
6	Aprepitant in adolescent patients for prevention of chemotherapy‐induced nausea and vomiting: A randomized, double‐blind, placebo‐controlled study of efficacy and tolerability 2008 ·Pediatric Blood & Cancer ·Lia Gore, Sant P. Chawla, Antônio Sérgio Petrilli, Molly Hemenway, (unknown), (unknown), Alexandra D. Carides, Arlene Taylor, (unknown), J L Valentine, Judith K. Evans, Bettina Oxenius, (unknown)	66
7	A Randomized, Double-Blind Comparison of the NK1 Antagonist, Aprepitant, Versus Ondansetron for the Prevention of Postoperative Nausea and Vomiting 2007 ·Anesthesia & Analgesia ·Tong J. Gan, Christian C. Apfel, Anthony L. Kovac, Beverly K. Philip, Neil Singla, Harold S. Minkowitz, Ashraf S. Habib, (unknown), Alexandra D. Carides, Hong Zhang, Kevin Horgan, Judith K. Evans, (unknown)	128
8	Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant 2007 ·Current Medical Research and Opinion ·Pierre Diemunsch, Christian C. Apfel, Tong J. Gan, Keith Candiotti, Beverly K. Philip, Jacques E. Chelly, Alexandra D. Carides, Judith K. Evans, Tony W. Ho, Theodore F. Reiss	39
9	The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials 2005 ·European Journal of Cancer ·David Warr, Steven M. Grunberg, Richard J. Gralla, Paul J. Hesketh, Fausto Roila, Ronald de Wit, Alexandra D. Carides, Arlene Taylor, Judith K. Evans, Kevin Horgan	100
10	Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT₃ antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin 2005 ·Cancer ·Richard J. Gralla, Ronald de Wit, Jørn Herrstedt, Alexandra D. Carides, Juliana Ianus, (unknown), Judith K. Evans, Kevin Horgan	81
11	Indinavir and Rifabutin Drug Interactions in Healthy Volunteers 2004 ·The Journal of Clinical Pharmacology ·Walter K. Kraft, Jacqueline B. McCrea, Gregory A. Winchell, Alexandra D. Carides, (unknown), Eric Woolf, (unknown), Paul Deutsch, Howard Greenberg, Scott A. Waldman	27
12	Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting 2003 ·Cancer ·(unknown), (unknown), Alexandra D. Carides, (unknown), (unknown), (unknown), Judith K. Evans, Kevin Horgan, Francesca Lawson, (unknown)	459
13	Establishing the dose of the oral NK₁ antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting 2003 ·Cancer ·Sant P. Chawla, Steven M. Grunberg, Richard J. Gralla, Paul J. Hesketh, (unknown), M. Elmer, (unknown), Arlene Taylor, Alexandra D. Carides, Judith K. Evans, Kevin Horgan	177
14	Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections 2003 ·Annals of Surgery ·Joseph S. Solomkin, Albert E. Yellin, Ori D. Rotstein, Nicolas V. Christou, E. Patchen Dellinger, José M. Tellado, Osvaldo Malafaia, Álvaro Fernández-Quilez, Kyuran A. Choe, Alexandra D. Carides, Vilas Satishchandran, Hedy Teppler	148
15	Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869 2002 ·Cancer ·Simon Van Belle, M. Lichinitser, Rudolph M. Navari, August Garin, Marc Decramer, Alain Rivière, Myo Thant, (unknown), Binh Bui, (unknown), Marina De Smet, N. Michiels, (unknown), Alexandra D. Carides, Judith K. Evans, Barry J. Gertz	115
16	A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in Adults 2002 ·Clinical Infectious Diseases ·Guillermo Ortíz, (unknown), Ian R. Friedland, Gail L. Woods, Alexandra D. Carides, (unknown)	76
17	Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity 1999 ·The Journal of Clinical Pharmacology ·Jacqueline B. McCrea, Thomayant Prueksaritanont, Barry J. Gertz, Alexandra D. Carides, Lisa Gillen, (unknown), (unknown), Cynthia Miller‐Stein, Barbara A. Osborne, Scott A. Waldman	49
18	Simultaneous investigation of indinavir nonlinear pharmacokinetics and bioavailability in healthy volunteers using stable isotope labeling technique: Study design and model‐independent data analysis 1999 ·Journal of Pharmaceutical Sciences ·K. C. Yeh, Julie A. Stone, Alexandra D. Carides, Paul Rolan, Eric Woolf, William D. Ju	26
19	Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia 1999 ·Kidney International ·Shahnaz Shahinfar, Roger L. Simpson, Alexandra D. Carides, Balasamy Thiyagarajan, (unknown), Jason G. Umans, Joan H. Parks, Fredric L. Coe, (unknown)	52
20	DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan* 1997 ·Clinical Pharmacology & Therapeutics ·Michael R. Goldberg, Man‐Wai Lo, David D. Christ, (unknown), Christine Furtek, Ohad Amit, Alexandra D. Carides, Jérôme Biollaz, Vincent Piguet, Juerg Nussberger, Hans R. Brunner	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact